Seelos Therapeutics Stock Market Value
| SEEL Stock | USD 0.39 0.11 22.00% |
| Symbol | Seelos |
Seelos Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Seelos Therapeutics' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Seelos Therapeutics.
| 10/24/2024 |
| 11/23/2024 |
If you would invest 0.00 in Seelos Therapeutics on October 24, 2024 and sell it all today you would earn a total of 0.00 from holding Seelos Therapeutics or generate 0.0% return on investment in Seelos Therapeutics over 30 days. Seelos Therapeutics is related to or competes with ATAI Life, Mind Medicine, GH Research, Cybin, Pulmatrix, Capricor Therapeutics, and Akari Therapeutics. Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization ... More
Seelos Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Seelos Therapeutics' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Seelos Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.27) | |||
| Maximum Drawdown | 104.99 | |||
| Value At Risk | (25.00) | |||
| Potential Upside | 13.18 |
Seelos Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Seelos Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Seelos Therapeutics' standard deviation. In reality, there are many statistical measures that can use Seelos Therapeutics historical prices to predict the future Seelos Therapeutics' volatility.| Risk Adjusted Performance | (0.19) | |||
| Jensen Alpha | (3.29) | |||
| Total Risk Alpha | (5.45) | |||
| Treynor Ratio | 4.49 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Seelos Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Seelos Therapeutics Backtested Returns
Seelos Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.23, which indicates the firm had a -0.23% return per unit of risk over the last 3 months. Seelos Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Seelos Therapeutics' Coefficient Of Variation of (389.04), variance of 172.31, and Risk Adjusted Performance of (0.19) to confirm the risk estimate we provide. The entity has a beta of -0.75, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Seelos Therapeutics are expected to decrease at a much lower rate. During the bear market, Seelos Therapeutics is likely to outperform the market. At this point, Seelos Therapeutics has a negative expected return of -3.13%. Please make sure to validate Seelos Therapeutics' treynor ratio and the relationship between the skewness and price action indicator , to decide if Seelos Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.71 |
Good predictability
Seelos Therapeutics has good predictability. Overlapping area represents the amount of predictability between Seelos Therapeutics time series from 24th of October 2024 to 8th of November 2024 and 8th of November 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Seelos Therapeutics price movement. The serial correlation of 0.71 indicates that around 71.0% of current Seelos Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.71 | |
| Spearman Rank Test | 0.52 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Seelos Therapeutics lagged returns against current returns
Autocorrelation, which is Seelos Therapeutics otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Seelos Therapeutics' otc stock expected returns. We can calculate the autocorrelation of Seelos Therapeutics returns to help us make a trade decision. For example, suppose you find that Seelos Therapeutics has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Seelos Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Seelos Therapeutics otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Seelos Therapeutics otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Seelos Therapeutics otc stock over time.
Current vs Lagged Prices |
| Timeline |
Seelos Therapeutics Lagged Returns
When evaluating Seelos Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Seelos Therapeutics otc stock have on its future price. Seelos Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Seelos Therapeutics autocorrelation shows the relationship between Seelos Therapeutics otc stock current value and its past values and can show if there is a momentum factor associated with investing in Seelos Therapeutics.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Seelos OTC Stock
Seelos Therapeutics financial ratios help investors to determine whether Seelos OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Seelos with respect to the benefits of owning Seelos Therapeutics security.